Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. - Wikidata - awgldk - TriplyDB

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

http://www.wikidata.org/entity/Q42868532

about

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Decongestion: Diuretics and other therapies for hospitalized heart failure Focus on renal congestion in heart failure Predicting mortality in patients with acute heart failure: Role of risk scores Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review Organ-specific responses to circulatory disturbances in heart failure: new insights Delayed graft function in the kidney transplant Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group End points for comparative effectiveness research in heart failure Patient selection in heart failure with preserved ejection fraction clinical trials Cardiorenal syndrome: a cardiologist's perspective of pathophysiology Management of the cardiorenal syndrome in decompensated heart failure Agents with vasodilator properties in acute heart failure: how to design successful trials Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF Adenosine receptors as drug targets--what are the challenges?Almanac 2011: Heart Failure. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology.Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study Cardiac purinergic signalling in health and disease Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.A patient with heart failure and worsening kidney function Renal subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): the end of nesiritide as a cardiorenal therapeutic?Diuretic use in heart failure and outcomes.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction Cardiorenal syndrome in acute heart failure syndromes.In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.Renal hyperfiltration related to diabetes mellitus and obesity in human disease.De novo acute heart failure and acutely decompensated chronic heart failure The kidney in heart failure: an update.Evidence of Mild Liver Dysfunction Identifies Stable Heart Failure Outpatients with Reversible Renal Dysfunction.The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function.Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)The Impact of Worsening Heart Failure in the United States

P2860

Q26745670-F190D01C-7E3B-4068-A295-D9541AC12CE0 Q26750884-6CF96C3F-DFCF-4C7D-9CB6-A2AE34F69482 Q26769905-2E216FBC-ED2C-4782-BF91-1F129BD73B4F Q26771109-B76D7D79-FAA2-4355-AF96-47C485CA5BA6 Q26800965-FCBF426A-33A4-4F50-A6EE-96C25134109A Q26822738-5BB967D5-3E97-442F-90DF-DF09DCF4C1B8 Q26824506-7A872863-4E02-40F3-B54F-260E8CD146E2 Q27000455-9195F376-4212-4A09-B6CA-19293DE01CDA Q27012843-C1D30D93-F626-45AC-8FDF-7AC1BC89EC42 Q27015845-0F936782-5EB0-4DD3-90DE-A69D51758CBF Q27023089-A0B397A7-51CE-4FF2-92B1-DE09E731165D Q27028203-E31BDA96-FEC6-49FD-94B5-A3980ADF1C78 Q28084239-2BB34F30-4F0E-486B-B916-966BE797EAC2 Q28740781-29259E58-1A1B-4FBB-95C1-C1E94F8BB196 Q29346491-68ADC775-3ECC-4FB9-8286-A17ECC52FC48 Q30451215-ABD69916-523C-42C4-AE5A-EBEBF64E406F Q31145367-4FCC15C8-C1CB-4351-9EFA-4576F5CE3F41 Q33165093-AE77BC41-C22A-472A-8952-E89732CE2E04 Q33698744-CCD7F0F8-CDF8-4ACD-85D8-DA89A73C8BE2 Q33753500-78513A7B-D243-44CC-8D7C-BB8060CFB50F Q33845755-9BA022F0-2DFB-4182-B277-4267530034BB Q33917887-4F478DF7-E921-48E0-9449-3C4D40ABA36D Q34164006-5B605A72-06F0-48D5-8A66-78DC38D6F58E Q34292920-750E13ED-0519-463C-BA78-29963E4B2239 Q34334888-E87B931F-8308-42E1-905C-411F5717CE44 Q34357452-234A510C-3434-4E33-A7F5-B7F07FEBF621 Q34625223-C394C349-0A22-4E32-A8BE-956889B0D0C4 Q34665867-24149083-82EB-451A-BAEA-C4F5195D65F3 Q35026394-51FA13EB-5AC3-4534-BC2C-3E446F3B646D Q35057622-D1C3B98B-B094-4E75-905D-06654EAF5EDD Q35432267-4CFF2B65-D0F6-408D-88A0-ABCCBC89542E Q35673442-8E6F3188-FFA2-4F16-9092-F3054A98815E Q35675983-B613E01C-1B90-4311-96BA-474A54E3FD70 Q35737499-3B31432F-21EC-441E-8689-B2808C44AB10 Q35773130-292D920C-5E42-4460-8599-154C95DF3284 Q35779122-84B405C4-160A-421F-95EC-5C53E6ABF201 Q35787419-741313CA-9820-4EFF-81B5-099B185D57AA Q36054705-0AC2B4AD-D823-432E-BBE4-A66B446F7679 Q36089337-E9592AC6-C4A2-4C01-8023-BF3E7F05DC19 Q36168137-E6F3FC0D-6DE5-429E-8BDB-7813BA94FC72

P2860

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

http://www.wikidata.org/entity/Q42868532

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@en

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@nl

type

label

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@en

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@nl

prefLabel

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@en

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@nl

P1433

Q42868532-76CFD18A-A57A-4438-8F30-5691AADCE7C4

P1476

Q42868532-4FCC704B-A307-4334-A638-BEB0A03B4BCD

P2093

Q42868532-033C3BDC-FA8F-4990-905B-2B6D355146DD

Q42868532-1DABF589-BCE1-4009-83C3-CC276B9E87C8

Q42868532-2A027605-6F00-4AC9-8753-DEEBCD996C9B

Q42868532-343BE91B-0199-42DC-8DC2-E1AA52C487AE

Q42868532-403B525A-3E9A-4479-810C-046FE76C7443

Q42868532-4C0662B2-6757-4F5F-92FC-A6D9B5ABAC56

Q42868532-868C5274-FA42-4CE4-A3BB-A7BFED5F1407

Q42868532-A07A6D64-0FAB-4843-8EED-63A05753969C

Q42868532-AF615525-21D1-4EB9-974A-0244ED24F96E

Q42868532-CBC657C9-1021-4710-BE43-848325E33785

P304

Q42868532-1A8EF3A8-68C0-4E2D-9D8F-EAF11EAD526E

P31

Q42868532-6F728250-CCEA-4C0F-8BC2-A59CB18B2AF9

P356

Q42868532-900D3E88-34E1-45FF-B7D1-26CF058C5F56

P407

Q42868532-3BB21C02-D1C0-4C96-B79B-89A2CC5BDC59

P433

Q42868532-CD117A00-54A7-4CF2-AF58-D1148ACC8FB7

P478

Q42868532-E906656B-9FF6-40AF-8EC0-40BDD7AEED5D

P50

Q42868532-13DAD8DD-DE6A-4B3F-9503-F351440972A8

Q42868532-26FB3EF5-BEEF-4503-844E-7223E7D0C9B3

Q42868532-9EB733C7-81C8-4A82-8DA9-EB573F7C7779

Q42868532-DCACE6F8-EAF0-4054-981C-08A1FA5980C6

P577

Q42868532-BB9BC542-B837-49E9-B489-7932FE6DC4BD

P5875

Q42868532-9855A201-7237-4276-9182-0CAA69FEA6DB

P698

Q42868532-D997D4BE-C83F-44FD-A4AF-2AA5E4B72470

P921

Q42868532-00379295-D817-4534-BEB0-C1A8A622F0D3

P356

P1433

The New England Journal of Medicine

P1476

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.

@en

P2093

Adriaan Voors

http://www.w3.org/2001/XMLSchema#string

Barry M Massie

http://www.w3.org/2001/XMLSchema#string

Beth Davison Weatherley

http://www.w3.org/2001/XMLSchema#string

Christina M Salerno

http://www.w3.org/2001/XMLSchema#string

Daniel M Bloomfield

http://www.w3.org/2001/XMLSchema#string

George A Mansoor

http://www.w3.org/2001/XMLSchema#string

Howard C Dittrich

http://www.w3.org/2001/XMLSchema#string

John G F Cleland

http://www.w3.org/2001/XMLSchema#string

John R Teerlink

http://www.w3.org/2001/XMLSchema#string

Michael M Givertz

http://www.w3.org/2001/XMLSchema#string

P304

1419-1428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0912613

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Ponikowski

Christopher M O'Connor

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47356393

http://www.w3.org/2001/XMLSchema#string

P698

20925544

http://www.w3.org/2001/XMLSchema#string

P921